Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 3:54 AM
Ignite Modification Date: 2025-12-26 @ 2:44 AM
NCT ID: NCT02962102
Description: None
Frequency Threshold: 0
Time Frame: 7 days for hypercalcemia and 28 days for all-cause mortality
Study: NCT02962102
Study Brief: Activated Vitamin D for the Prevention and Treatment of Acute Kidney Injury
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Calcifediol Calcifediol 400mcg PO/NGT/OGT x 1, followed by 200mcg PO/NGT/OGT daily x 4 Calcifediol: Calcifediol 400mcg PO/NGT/OGT x 1, followed by 200mcg PO/NGT/OGT daily x 4 10 None 0 51 1 51 View
Calcitriol Calcitriol 4mcg PO/NGT/OGT daily x 5 days Calcitriol: Calcitriol 4mcg PO/NGT/OGT daily x 5 16 None 0 50 1 50 View
Placebo Equal volume of medium chain triglyceride (MCT) oil daily x 5 days Placebos: Placebo (medium chain triglyceride oil) daily x 5 10 None 0 49 0 49 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Hypercalcemia SYSTEMATIC_ASSESSMENT Endocrine disorders None View